Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Federal Trade Commission
Argus Health
US Army

Generated: June 25, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,231,095

« Back to Dashboard

Summary for Patent: 5,231,095
Title: S-timolol hemihydrate
Abstract:A novel compound and compositions containing S-(-)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5 thiadiazole hemihydrate useful for administration to a patient particularly for topical administration as a pharmaceutical agent for treating known conditions and disorders treatable with timolol.
Inventor(s): Peralampi; Markku (Kangasala, FI)
Assignee: Leiras Oy (Turku, FI)
Application Number:07/663,853
Patent Claims: 1. A compound which is S-(-)-3-morpholino-4-(3-tertbutylamino-2-hydroxypropoxy)-1,2,5-thiadiazole hemihydrate, i.e., S-timolol hemihydrate, of the formula: ##STR2##

2. A pharmaceutical composition comprising as the active agent S-(-)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazol e hemihydrate, i.e., S-timolol hemihydrate, of the formula: ##STR3## together with pharmaceutically acceptable adjuvants.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
US Army
Johnson and Johnson
Daiichi Sankyo
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.